Tompkins Financial Corp Reduces Stock Holdings in Aflac Incorporated (NYSE:AFL)

Tompkins Financial Corp trimmed its position in Aflac Incorporated (NYSE:AFL) by 82.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 333 shares of the financial services provider’s stock after selling 1,600 shares during the quarter. Tompkins Financial Corp’s holdings in Aflac were worth $37,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Carmel Capital Partners LLC grew its position in Aflac by 4.4% in the third quarter. Carmel Capital Partners LLC now owns 3,929 shares of the financial services provider’s stock worth $439,000 after acquiring an additional 165 shares during the period. Assetmark Inc. grew its holdings in shares of Aflac by 0.7% during the 3rd quarter. Assetmark Inc. now owns 1,584,552 shares of the financial services provider’s stock worth $177,153,000 after purchasing an additional 10,487 shares during the period. Verdence Capital Advisors LLC increased its position in shares of Aflac by 3.9% during the 3rd quarter. Verdence Capital Advisors LLC now owns 14,332 shares of the financial services provider’s stock worth $1,602,000 after purchasing an additional 537 shares during the last quarter. Rockbridge Investment Management LCC purchased a new stake in Aflac in the 3rd quarter valued at about $222,000. Finally, Executive Wealth Management LLC acquired a new position in Aflac in the third quarter valued at about $394,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Stock Performance

Shares of AFL stock opened at $108.27 on Friday. The company has a market cap of $60.15 billion, a P/E ratio of 16.31, a PEG ratio of 2.11 and a beta of 0.96. The firm has a fifty day moving average price of $110.33 and a 200 day moving average price of $98.56. The company has a current ratio of 0.08, a quick ratio of 0.10 and a debt-to-equity ratio of 0.32. Aflac Incorporated has a 12 month low of $75.07 and a 12 month high of $115.50.

Aflac (NYSE:AFL) last released its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, beating analysts’ consensus estimates of $1.69 by $0.47. The business had revenue of $2.95 billion for the quarter, compared to the consensus estimate of $4.30 billion. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The business’s revenue for the quarter was down 40.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.84 EPS. Sell-side analysts predict that Aflac Incorporated will post 7.17 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 2nd. Stockholders of record on Wednesday, November 20th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.85%. The ex-dividend date is Wednesday, November 20th. Aflac’s payout ratio is 30.12%.

Wall Street Analysts Forecast Growth

AFL has been the topic of a number of research analyst reports. Bank of America boosted their price target on shares of Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. TD Cowen began coverage on Aflac in a research report on Wednesday, October 9th. They issued a “hold” rating and a $102.00 target price on the stock. Morgan Stanley raised their price target on Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a research report on Monday, August 19th. Barclays initiated coverage on Aflac in a report on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 price objective on the stock. Finally, UBS Group raised their target price on Aflac from $84.00 to $109.00 and gave the company a “neutral” rating in a report on Wednesday, August 14th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Aflac presently has a consensus rating of “Hold” and an average target price of $97.93.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.